Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M79.3Revenue $M18.1Net Margin (%)-1,925.3Altman Z-Score-15.4
Enterprise Value $M58.3EPS $-1.0Operating Margin %-1,842.6Piotroski F-Score1
P/E(ttm)--Beneish M-Score-2.4Pre-tax Margin (%)-1,925.3Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales25.55-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-65.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-158.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M55.1ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AVEO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AVEOSeth Klarman 2014-12-31 Sold Out -0.07%$0.65 - $1.17
($0.91)
$ 1.4458%Sold Out0
AVEOGeorge Soros 2014-09-30 Sold Out $1.09 - $1.79
($1.26)
$ 1.4414%Sold Out0
AVEOGeorge Soros 2014-06-30 Buy $1.02 - $1.72
($1.29)
$ 1.4412%New holding49,076
AVEOSeth Klarman 2013-06-30 Reduce-0.26%$2.34 - $8.27
($4.27)
$ 1.44-66%Reduce 21.90%3,829,350
AVEOGeorge Soros 2011-12-31 Sold Out -0.0031%$14.53 - $17.35
($8.42)
$ 1.44-83%Sold Out0
AVEOSeth Klarman 2011-09-30 Add0.29%$15.12 - $20.77
($17.66)
$ 1.44-92%Add 12.79%5,000,000
AVEOGeorge Soros 2011-09-30 Reduce-0.04%$15.12 - $20.77
($17.66)
$ 1.44-92%Reduce 92.80%11,600
AVEOSeth Klarman 2011-06-30 Add0.78%$13.06 - $20.66
($16.79)
$ 1.44-91%Add 25.76%4,433,010
AVEOGeorge Soros 2011-06-30 Buy 0.05%$13.06 - $20.66
($16.79)
$ 1.44-91%New holding161,000
AVEOSeth Klarman 2011-03-31 Add1.15%$13.15 - $15.02
($14.21)
$ 1.44-90%Add 76.25%3,525,000
AVEOSeth Klarman 2010-12-31 Buy 1.68%$13.84 - $17.41
($15.14)
$ 1.44-90%New holding2,000,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AVEO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AVEO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Dallas Matthew DVP, Finance 2015-01-16Sell3,075$0.8275.61 view
Gyuris JenoSVP, Chief Scientific Officer 2015-01-07Sell4,484$0.880 view
Vittiglio JosephSVP, General Counsel 2015-01-07Sell4,484$0.880 view
Dallas Matthew DVP, Finance 2015-01-07Sell519$0.880 view
BAILEY MICHAEL PPresident & CEO 2015-01-07Sell4,484$0.880 view
Dallas Matthew DVP, Finance 2014-07-01Sell0$080 view
BAILEY MICHAEL PChief Business Officer 2014-01-30Sell5,430$1.64-12.2 view
Slichenmyer WilliamChief Medical Officer 2014-01-30Sell5,430$1.64-12.2 view
Gyuris JenoSVP, Chief Scientific Officer 2014-01-30Sell5,430$1.64-12.2 view
Vittiglio JosephSVP, General Counsel 2014-01-30Sell5,430$1.64-12.2 view

Quarterly/Annual Reports about AVEO:

News about AVEO:

Articles On GuruFocus.com
Wild Card Wonders, Shopping for 52-Week Lows Sep 28 2013 
Sleepy Sector Wakes Up - Billionaires Hold Biotechs in 52-week Low Sep 03 2013 
comment on AVEO Mar 15 2013 
comment on AVEO Mar 15 2013 
Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA Dec 16 2012 
Seth Klarman’s Baupost Group Buys Microsoft Corp., BP, Allied Nevada Gold, Sells Audiovox Corp. Aug 12 2011 
Seth Klarman’s Baupost Group Q1 Portfolio Update; Buys ANV, SCMR, PDLI, AVEO May 14 2011 
AVEO Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 11 2011 
Two Picks from Seth Klarman: PDLI, AVEO Feb 22 2011 
Hedge Fund Baupost Group buys PDLI, AVEO, ALR, Sells LSTZA, UFS, SLRC, EXXI Feb 11 2011 

More From Other Websites
AVEO Oncology Announces Additional Biomarker Analyses from BATON-CRC Tivozanib Study to be Presented... Jun 30 2015
AVEO Oncology Announces Additional Biomarker Analyses from BATON-CRC Tivozanib Study to be Presented... Jun 30 2015
With spinout planned for next week, Baxalta provides hemophilia update Jun 24 2015
AVEO Announces FDA Update for Tivozanib in Colorectal Cancer Jun 11 2015
AVEO Announces FDA Update for Tivozanib in Colorectal Cancer Jun 11 2015
Tivozanib Is the Gift That Keeps on Giving for Aveo Jun 04 2015
BUZZ-U.S. STOCKS ON THE MOVE-Aveo, Biglari, Dara, Gevo, Molycorp Jun 04 2015
Aveo set to soar today on news of potential drug approval in Europe Jun 04 2015
AVEO Announces Receipt of European Regulatory Guidance Regarding Potential Marketing Authorization... Jun 03 2015
AVEO Announces Receipt of European Regulatory Guidance Regarding Potential Marketing Authorization... Jun 03 2015
AVEO PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments... Jun 03 2015
The 4 Overlooked Winners of ASCO Jun 02 2015
AVEO Oncology to Present at Jefferies 2015 Global Healthcare Conference May 29 2015
AVEO Oncology Announces New Corporate Headquarters in Cambridge, Massachusetts May 26 2015
AVEO Oncology Announces New Corporate Headquarters in Cambridge, Massachusetts May 26 2015
Can These Stocks Provide Investors with Further Gains? May 22 2015
BlackBerry, Monro Muffler, Valeant In Thursday's After-Hours Movers May 21 2015
How to Evaluate a 50% Move in AVEO May 21 2015
What's Up With The Delayed Reaction In Aveo Pharmaceuticals? May 21 2015
AVEO Oncology Announces Presentation of Final Results of Extension Study 902 and FDA Regulatory... May 20 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK